SIRT2 and breast carcinoma: Conversely, an upregulation emerged in genes associated with the inhibition of breast cancer progression, including SIRT2, MST1, and ULK1, indicating the therapeutic potential of the peptide (Fig. 2, A and B) (20, 21).